Jim Simons Avrobio, Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Avrobio, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 888,167 shares of AVRO stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

888,167

Previous 758,943 17.03%

Holding current value

$1.31 Million

Previous $1.03 Million 10.17%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.15 - $1.48 $148,607 - $191,251	129,224 Added 17.03%	888,167 $1.14 Million
Q4 2023 Feb 13, 2024	BUY	$1.22 - $1.62 $293,380 - $389,571	240,476 Added 46.38%	758,943 $1.03 Million
Q3 2023 Nov 14, 2023	SELL	$0.98 - $1.62 $43,218 - $71,442	-44,100 Reduced 7.84%	518,467 $798,000
Q2 2023 Aug 11, 2023	SELL	$0.58 - $1.31 $6,264 - $14,148	-10,800 Reduced 1.88%	562,567 $534,000
Q1 2023 May 12, 2023	SELL	$0.76 - $1.82 $219,564 - $525,798	-288,900 Reduced 33.5%	573,367 $573,000

Q4 2022 Feb 13, 2023	SELL	$0.64 - $0.91 $230,319 - $327,485	-359,874 Reduced 29.45%	862,267 $615,000
Q3 2022 Nov 14, 2022	SELL	$0.68 - $1.11 $226,888 - $370,361	-333,659 Reduced 21.45%	1,222,141 $785,000
Q2 2022 Aug 12, 2022	BUY	$0.75 - $1.33 $503,025 - $892,031	670,700 Added 75.78%	1,555,800 $1.43 Million
Q1 2022 May 13, 2022	BUY	$1.29 - $4.04 $727,689 - $2.28 Million	564,100 Added 175.73%	885,100 $1.17 Million
Q4 2021 Feb 11, 2022	SELL	$3.45 - $6.05 $290,145 - $508,805	-84,100 Reduced 20.76%	321,000 $1.24 Million
Q3 2021 Nov 12, 2021	BUY	$5.53 - $9.28 $1.75 Million - $2.93 Million	316,100 Added 355.17%	405,100 $2.26 Million
Q2 2021 Aug 13, 2021	BUY	$7.84 - $12.6 $697,760 - $1.12 Million	89,000 New	89,000 $791,000
Q1 2021 May 13, 2021	SELL	$10.54 - $19.3 $427,923 - $783,580	-40,600 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$12.79 - $17.1 $323,587 - $432,630	25,300 Added 165.36%	40,600 $566,000
Q3 2020 Nov 13, 2020	SELL	$12.99 - $19.41 $275,777 - $412,074	-21,230 Reduced 58.12%	15,300 $199,000
Q2 2020 Aug 13, 2020	BUY	$12.19 - $22.96 $445,300 - $838,728	36,530 New	36,530 $637,000
Q3 2019 Nov 13, 2019	SELL	$14.12 - $23.44 $224,508 - $372,696	-15,900 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$13.21 - $27.29 $210,039 - $433,911	15,900 New	15,900 $259,000

Others Institutions Holding AVRO

# of Institutions

Shares Held

28.1M

Call Options Held

Put Options Held

100

View Full List

About AVROBIO, Inc.

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Market Cap $64.8M
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

More about AVRO

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account